Concepedia

Balaji Muralikrishnan

BM

Statistics

Publications

5

Citations

119

H-Index

5

Active since

2016

Affiliations

Rajiv Gandhi Centre for Biotechnology(Current)

National Chemical Laboratory

Balaji Muralikrishnan is an author at Rajiv Gandhi Centre for Biotechnology specializing in life sciences, pharmacology, and antibacterial agents.

Publications per year

2016–2024

5

Publications

5

Anti-microbial activity of chrysomycin A produced by Streptomyces sp. against Mycobacterium tuberculosis

Balaji Muralikrishnan, Vipin Mohan Dan, Vellekkatt Jamsheena et al. · RSC Advances · 2017 · 43 citations · Full text

, , +11

Streptomyces sp metabolite(s) promotes Bax mediated intrinsic apoptosis and autophagy involving inhibition of mTOR pathway in cervical cancer cell lines

Vipin Mohan Dan, Balaji Muralikrishnan, Rahul Sanawar et al. · Scientific Reports · 2018 · 24 citations · Full text

, , +17

Chrysomycin A inhibits the topoisomerase I of Mycobacterium tuberculosis

Balaji Muralikrishnan, Lekshmi K. Edison, Azger Dusthackeer et al. · The Journal of Antibiotics · 2022 · 22 citations

, , +12

The multiple stress responsive transcriptional regulator Rv3334 of <i>Mycobacterium tuberculosis</i> is an autorepressor and a positive regulator of <i>kstR</i>

Roshna Lawrence Gomez, Leny Jose, Ranjit Ramachandran et al. · FEBS Journal · 2016 · 17 citations · Full text

, , +15

Proteomic Analysis of the <i>Mycobacterium tuberculosis</i> Outer Membrane for Potential Implications in Uptake of Small Molecules

Aseem Palande, Saniya Patil, Anjali Veeram et al. · ACS Infectious Diseases · 2024 · 13 citations

, , +17

1–5 of 5